{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:46:24Z","timestamp":1767984384065,"version":"3.49.0"},"reference-count":33,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: The optimal revascularization strategy for patients with left main coronary artery (LMCA) disease has been repeatedly addressed in randomized controlled trials (RCTs), although outcomes from real-life clinical studies are still poorly investigated. Objectives: This retrospective study aimed to assess the complete 5-year outcomes for individuals with multivessel coronary artery disease (MVD) involving LMCA disease treated with coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) as recommended by a local HT. Methods: From 2016 to 2019, 176 Heart Team (HT) meetings were held. Primary and secondary endpoints of 267 patients with MVD involving LMCA disease qualified either for CABG or PCI (109 and 158 patients, respectively) with subsequent optimal medical therapy (OMT) were assessed. The primary endpoint of the study was as an overall mortality, while secondary endpoints contained major adverse cardiac and cerebrovascular events (MACCE)\u2014specifically, stroke, myocardial infarction (MI), repeat revascularization (RR), and the individual components of MACCE. Results: At 5 years, we found no significant difference in overall mortality between the both cohorts (22.9%-CABG vs. 24.7%-PCI, p = 0.74). The rate of MI was higher in patients treated percutaneously (7.3% vs. 15.8% for PCI, p = 0.04), while the incidence of stroke was higher in patients who underwent CABG (3.8% vs. 11.0% for CABG, p = 0.02). A MACCE occurrence was higher in PCI cohort (77.2% vs. 55.0%, p &lt; 0.001), mainly driven by higher rates of RR was higher in patients treated percutaneously (32.9% vs. 13.8%, p &lt; 0.001). Conclusions: For patients with LMCA disease, neither CABG nor PCI following HT decisions showed overwhelming superiority in real-life clinical practice: occurrence of all-cause death was similar, rates of MACCE, MI, and repeat revascularization advocated CABG, while incidence of strokes favored PCI.<\/jats:p>","DOI":"10.3390\/jcm14165747","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T15:44:21Z","timestamp":1755186261000},"page":"5747","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention for Left Main Coronary Artery Disease\u2014Long-Term Outcomes"],"prefix":"10.3390","volume":"14","author":[{"given":"Szymon","family":"Jonik","sequence":"first","affiliation":[{"name":"1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Gumi\u0119\u017cna","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Baru\u015b","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rados\u0142aw","family":"Wilimski","sequence":"additional","affiliation":[{"name":"Department of Heart, Thorax Surgery and Transplantology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9665-7129","authenticated-orcid":false,"given":"Mariusz","family":"Ku\u015bmierczyk","sequence":"additional","affiliation":[{"name":"Department of Heart, Thorax Surgery and Transplantology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Opolski","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Grabowski","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Kochman","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenon","family":"Huczek","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Mazurek","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41569-018-0001-4","article-title":"Left main coronary artery disease: Pathophysiology, diagnosis, and treatment","volume":"15","author":"Collet","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/heartjnl-2011-301596","article-title":"Prevalence and non-invasive predictors of left main or three-vessel coronary disease: Evidence from a collaborative international meta-analysis including 22,740 patients","volume":"98","author":"Presutti","year":"2012","journal-title":"Heart"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/heartjnl-2019-315707","article-title":"Recent advances in percutaneous coronary intervention","volume":"106","author":"Hoole","year":"2020","journal-title":"Heart"},{"key":"ref_5","first-page":"419","article-title":"Recent Advances in Antiplatelet Therapy in Complex Percutaneous Coronary Intervention","volume":"11","author":"Spirito","year":"2022","journal-title":"Interv. Cardiol. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1056\/NEJMoa1909406","article-title":"Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease","volume":"381","author":"Stone","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/eurheartj\/ehab441","article-title":"Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease","volume":"43","author":"Wang","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/CIRCULATIONAHA.120.046039","article-title":"Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial","volume":"141","author":"Park","year":"2020","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0140-6736(19)31997-X","article-title":"Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial","volume":"394","author":"Thuijs","year":"2019","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jtcvs.2020.04.010","article-title":"Percutaneous coronary intervention versus coronary artery bypass graft for left main coronary artery disease: A meta-analysis","volume":"163","author":"Gallo","year":"2022","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_11","first-page":"42","article-title":"Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI\/CABG registry\/cohort-2)","volume":"96","author":"Watanabe","year":"2020","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcin.2022.10.016","article-title":"Real-World Examination of Revascularization Strategies for Left Main Coronary Disease in Ontario, Canada","volume":"16","author":"Tam","year":"2023","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ahj.2017.05.005","article-title":"Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients","volume":"190","author":"Palmerini","year":"2017","journal-title":"Am. Heart J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/S0140-6736(21)02334-5","article-title":"Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: An individual patient data meta-analysis","volume":"398","author":"Sabatine","year":"2021","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/j.jacc.2017.10.036","article-title":"Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial","volume":"70","author":"Baron","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(19)32972-1","article-title":"Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: Updated 5-year outcomes from the randomised, non-inferiority NOBLE trial","volume":"395","author":"Holm","year":"2020","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e000638","DOI":"10.1136\/openhrt-2017-000638","article-title":"All-cause mortality and major cardiovascular outcomes comparing percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: A meta-analysis of short-term and long-term randomised trials","volume":"4","author":"Laukkanen","year":"2017","journal-title":"Open Heart"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJMoa1412168","article-title":"Everolimus-eluting stents or bypass surgery for multivessel coronary disease","volume":"372","author":"Bangalore","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1056\/NEJMoa1610227","article-title":"Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease","volume":"375","author":"Stone","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jacc.2015.10.043","article-title":"Causes of Death Following PCI Versus CABG in Complex CAD: 5-Year Follow-Up of SYNTAX","volume":"67","author":"Milojevic","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"Serruys","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.jacc.2015.03.033","article-title":"Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study","volume":"65","author":"Ahn","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e008007","DOI":"10.1161\/CIRCINTERVENTIONS.118.008007","article-title":"Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score","volume":"12","author":"Shlofmitz","year":"2019","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(18)30423-9","article-title":"Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: A pooled analysis of individual patient data","volume":"391","author":"Head","year":"2018","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1016\/j.jacc.2018.09.012","article-title":"10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease","volume":"72","author":"Park","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_26","first-page":"392","article-title":"Percutaneous management of long and diffused coronary lesions using newer generation drug-eluting stents in routine clinical practice: Long-term outcomes and complication predictors","volume":"129","author":"Paszek","year":"2019","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.jcin.2016.09.044","article-title":"Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years","volume":"9","author":"Parasca","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Jonik, S., Marchel, M., Pedzich-Placha, E., Pietrasik, A., Rdzanek, A., Huczek, Z., Kochman, J., Budnik, M., Pi\u0105tkowski, R., and Scis\u0142o, P. (2022). Optimal Management of Patients with Severe Coronary Artery Disease following Multidisciplinary Heart Team Approach-Insights from Tertiary Cardiovascular Care Center. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19073933"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijcard.2018.12.003","article-title":"New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registry","volume":"280","author":"Tanaka","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/eurheartj\/eht059","article-title":"The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease","volume":"34","author":"Head","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jcin.2019.09.019","article-title":"Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial","volume":"13","author":"Giustino","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Spadafora, L., Pastena, P., Cacciatore, S., Betti, M., Biondi-Zoccai, G., D\u2019aScenzo, F., De Ferrari, G.M., De Filippo, O., Versaci, F., and Sciarretta, S. (2025). One-Year Prognostic Differences and Management Strategies between ST-Elevation and Non-ST-Elevation Myocardial Infarction: Insights from the PRAISE Registry. Am. J. Cardiovasc. Drugs, Online ahead of print.","DOI":"10.1007\/s40256-025-00739-8"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Abdulrahman, M., Alsabbagh, A., Kuntze, T., Lauer, B., and Ohlow, M.A. (2019). Impact of Hierarchy on Multidisciplinary Heart-Team Recommendations in Patients with Isolated Multivessel Coronary Artery Disease. J. Clin. Med., 8.","DOI":"10.3390\/jcm8091490"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5747\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:27:13Z","timestamp":1760034433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":33,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jcm14165747"],"URL":"https:\/\/doi.org\/10.3390\/jcm14165747","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]}}}